APA引用形式

Yacov, N., Kafri, P., Salem, Y., Propheta‐Meiran, O., Feldman, B., Breitbart, E., & Mendel, I. (2020). MOSPD2 is a therapeutic target for the treatment of CNS inflammation. Clin Exp Immunol.

シカゴスタイル引用形

Yacov, N., P. Kafri, Y. Salem, O. Propheta‐Meiran, B. Feldman, E. Breitbart, , I. Mendel. "MOSPD2 Is a Therapeutic Target for the Treatment of CNS Inflammation." Clin Exp Immunol 2020.

MLA引用形式

Yacov, N., et al. "MOSPD2 Is a Therapeutic Target for the Treatment of CNS Inflammation." Clin Exp Immunol 2020.